KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer - PubMed (original) (raw)

Clinical application of whole-genome sequencing of solid tumors for precision oncology.

Kim R, Kim S, Oh BB, Yu WS, Kim CW, Hur H, Son SY, Yang MJ, Cho DS, Ha T, Heo S, Jang JY, Yun JS, Kwack KS, Kim JK, Huh J, Lim SG, Han SU, Lee HW, Park JE, Kim CH, Roh J, Koh YW, Lee D, Kim JH, Lee GH, Noh CK, Jung YJ, Park JW, Sheen S, Ahn MS, Choi YW, Kim TH, Kang SY, Choi JH, Baek SY, Lee KM, Il Kim S, Noh SH, Kim SH, Hwang H, Joo E, Lee S, Shin JY, Yun JY, Park J, Yi K, Kwon Y, Lee WC, Park H, Lim J, Yi B, Koo J, Koh JY, Lee S, Lee Y, Lee BR, Connolly-Strong E, Ju YS, Kwon M. Kim R, et al. Exp Mol Med. 2024 Aug;56(8):1856-1868. doi: 10.1038/s12276-024-01288-x. Epub 2024 Aug 13. Exp Mol Med. 2024. PMID: 39138315 Free PMC article.